关键词：疫苗刺激；免疫系统；生物制剂；免疫力特定；疾病；
摘 要：Vaccines are biological preparations that stimulate a person’s immune system to produce immunity to a particular disease, protecting the person from that disease. Vaccines are usually administered through injections, orally, or intranasally. They can be used for both adults and children. Pediatric vaccines are used to immunize children against infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Vaccine Approval Process

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Global Adult and Pediatric Preventable Vaccine

Market Share 2014-2019

07.4 Five Forces Analysis

08. Market Segmentation by Type of Vaccine

08.1 Live Attenuated Vaccine

08.2 Killed Vaccine

08.3 Toxoid Vaccine

08.4 Genetically Modified/Engineered Vaccine

09. Market Segmentation by Product Type

09.1 Polysaccharide Vaccines

09.2 Conjugate Vaccines

10. Geographical Segmentation

11. Global Preventable Vaccines Market by Key

Geographies

11.1 Market Size and Forecast for US

11.2 Market Size and Forecast for EU

11.3 Market Size and Forecast for Japan

11.4 Market Size and Forecast for India

11.5 Market Size and Forecast for China

12. Global Pediatric Preventable Vaccines

Market

12.1 Global Pediatric Preventable Vaccines Market

12.1.1 Market Size and Forecast

12.2 Market Segmentation of Global Pediatric

Preventable Vaccines Market

12.3 Global Pediatric Hepatitis Vaccine Market

12.3.1 Market Size and Forecast

12.4 Global Pediatric HiB Vaccine Market

12.4.1 Market Size and Forecast

12.5 Global Pediatric MMR Vaccine Market

12.5.1 Market Size and Forecast

12.6.1 Market Size and Forecast

12.7 Global Pediatric Pneumococcal Vaccine Market

12.7.1 Market Size and Forecast

12.8 Global Pediatric Polio Vaccine Market

12.8.1 Market Size and Forecast

12.9 Global Pediatric Varicella Vaccine Market

12.9.1 Market Size and Forecast

12.10 Global Other Pediatric Vaccine Market

12.10.1 Market Size and Forecast

12.11 Global Pediatric Preventable Vaccines Market

2014 and 2019 (by percentage)

13. Global Adult Preventable Vaccines Market

13.1 Market Size and Forecast

13.2 Segmentation of Global Adult Preventable

Vaccines Market

13.3 Global Cervical Cancer Vaccine Market

13.3.1 Market Size and Forecast

13.4 Global Hepatitis Vaccine Market

13.4.1 Market Size and Forecast

13.5 Global Adult Influenza Vaccine Market

13.5.1 Market Size and Forecast

13.6 Global Adult Pneumococcal Vaccine Market

13.6.1 Market Size and Forecast

13.7 Global Adult Travel, Diphtheria-Tetanus, and

Miscellaneous Vaccines Market

13.7.1 Market Size and Forecast

14. Key Leading Countries

14.1 US

14.2 China

14.3 Japan

14.4 India

15. Buying Criteria

16. Market Growth Drivers

17. Drivers and their Impact

18. Market Challenges

19. Impact of Drivers and Challenges

20. Market Trends

21. Trends and their Impact

22. Vendor Landscape

22.1 Competitive Scenario

22.1.1 Key News

22.1.2 Mergers and Acquisitions

22.2 Market Share Analysis 2014

22.2.1 GlaxoSmithKline

22.2.2 Merck

22.2.3 Novartis

22.2.4 Pfizer

22.2.5 Sanofi

22.3 Other Prominent Vendors

23. Key Vendor Analysis

23.1 GlaxoSmithKline

23.1.1 Key Facts

23.1.2 Business Overview

23.1.3 Business Segmentation

23.1.4 Business Segmentation by Revenue 2012 and 2013

23.1.5 Sales by Geography

23.1.6 Pipeline Products

23.1.7 Business Strategy

23.1.8 Key Information

23.1.9 SWOT Analysis

23.2 Merck

23.2.1 Key Facts

23.2.2 Business Overview

23.2.3 Business Segmentation by Revenue 2013

23.2.4 Business Segmentation by Revenue 2012 and 2013

23.2.5 Sales by Geography

23.2.6 Business Strategy

23.2.7 Key Developments

23.2.8 SWOT Analysis

23.3 Novartis

23.3.1 Key Facts

23.3.2 Business Description

23.3.3 Business Segmentation

23.3.4 Revenue by Business Segmentation

23.3.5 Revenue Comparison 2012 and 2013

23.3.6 Sales by Geography

23.3.7 Business Strategy

23.3.8 Key Developments

23.3.9 SWOT Analysis

23.4 Pfizer

23.4.1 Key Facts

23.4.2 Business Overview

23.4.3 Business Segmentation by Revenue 2013

23.4.4 Business Segmentation by Revenue 2012 and 2013

23.4.5 Geographical Segmentation by Revenue

23.4.6 Business Strategy

23.4.7 Key Developments

23.4.8 SWOT Analysis

23.5 Sanofi

23.5.1 Key Facts

23.5.2 Business Description

23.5.3 Business Segmentation

23.5.4 Revenue by Business Segmentation

23.5.5 Revenue Comparison 2012 and 2013

23.5.6 Sales by Geography

23.5.7 Business Strategy

23.5.8 Key Developments

23.5.9 SWOT Analysis

24. Other Reports in this Series